Browsing by Author "833b1e30-4427-4817-990e-bb391655de8b"

Now showing items 1-4 of 4

    • Core outcomes set for trials in people with coronavirus disease 2019 
      Tong, Allison; Elliott, Julián H.; Azevedo, Luciano César; Baumgart, Amanda; Bersten, Andrew; Cervantes, Lilia; Chew, Derek P.; Cho, Yeoungjee; Cooper, Tess; Crowe, Sally; Douglas, Ivor S.; Evangelidis, Nicole; Flemyng, Ella; Hannan, Elyssa; Horby, Peter; Howel, Martin; Lee, Jaehee; Liu, Emma; Lorca, Eduardo; Lynch, Deena; Marshall, John C.; Matus González, Andrea; McKenzie, Anne; Manera, Karine E.; McLeod, Charlie; Mehta, Sangeeta; Mer, Mervyn; Morris, Andrew Conway; Nseir, Saad; Povoa, Pedro; Reid, Mark; Sakr, Yasser; Shen, Ning; Smyth, Alan R.; Snelling, Tom; Strippoli, Giovanni F. M.; Teixeira Pinto, Armando; Torres, Antoni; Turner, Tari; Viecelli, Andrea K.; Webb, Steve; Williamson, Paula R.; Woc-Colburn, Laila; Zhang, Junhua; Craig, Jonathan C. (Lippincott Williams & Wilkins, 2020)
      Objectives: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop ...
    • Coronavirus disease-19: an interim evidence synthesis of the world association for infectious diseases and ... 
      Abu-Raya, Bahaa; Migliori, Giovanni Battista; O’Ryan, Miguel; Edwards, Kathryn; Torres, Antoni; Alffenaar, Jan-Willem; Martson, Anne-Grete; Centis, Rosella; D'Ambrosio, Lia; Flanagan, Katie; Hung, Iván; Lauretani, Fulvio; Leung, Chi Chi; Leuridan, Elke; Maertens, Kirsten; Maggio, Marcello Giuseppe; Nadel, Simón; Hens, Niel; Niesters, Hubert; Osterhaus, Albert; Pontali, Emanuele; Principi, Nicola; Rossato Silva, Denise; Omer, Saad; Spanevello, Antonio; Sverzellati, Nicola; Tan, Tina; Torres Torreti, Juan Pablo; Visca, Dina; Esposito, Susanna (Frontiers Media, 2020)
      Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 ...
    • International survey to establish prioritized outcomes for trials in people with Coronavirus disease 2019 
      Evangelidis, Nicole; Tong, Allison; Howell, Martín; Teixeira Pinto, Armando; Elliott, Julián H.; Azevedo, Luciano César; Bersten, Andrew; Cervantes, Lilia; Chew, Derek P.; Crowe, Sally; Douglas, Ivor S.; Flemyng, Ella; Horby, Peter; Lee, Jaehee; Lorca, Eduardo; Lynch, Deena; Marshall, John C.; McKenzie, Anne; Mehta, Sangeeta; Mer, Mervyn; Morris, Andrew Conway; Nseir, Saad; Povoa, Pedro; Reid, Mark; Sakr, Yasser; Shen, Ning; Smyth, Alan R.; Snelling, Tom; Strippoli, Giovanni F. M.; Torres, Antoni; Turner, Tari; Webb, Steve; Williamson, Paula R.; Woc-Colburn, Laila; Zhang, Junhua; Baumgart, Amanda; Cabrera, Sebastián; Cho, Yeoungjee; Cooper, Tess; Guha, Chandana; Liu, Emma; Matus González, Andrea; McLeod, Charlie; Natale, Patrizia; Saglimbene, Valeria; Viecelli, Andrea K.; Craig, Jonathan C. (Lippincott Williams & Wilkins, 2020)
      Objectives: There are over 4,000 trials conducted in people with coronavirus disease 2019. However, the variability of outcomes and the omission of patient-centered outcomes may diminish the impact of these trials on ...
    • Severe community-acquired pneumonia: Assessment of severity criteria 
      Ewig, Santiago; Ruiz, Mauricio; Mensa, Josep; Marcos, Maria Angeles; Martinez, Jose Antonio; Arancibia, Francisco; Niederman, Michael S.; Torres, Antoni (American Lung Association, 1998)
      The purpose of the study was to validate the criteria used in the guidelines of the American Thoracic Society (ATS) for severe community- acquired pneumonia (CAP). Severe pneumonia was defined as admission to the intensive ...